During the first quarter of 2015, start-up companies raised a total of $2.74 billion, the third quarter in a row in which the record has been broken. (Last quarter’s total was $1.46 billion.) Biopharma companies pulled in an impressive $2.32 billion, half resulting from public start-up fundraising (PIPEs, IPOs, follow-ons). Medical device firms raised $72.5 million (77% from an IPO), and in vitro diagnostics companies combined for $350.4 million, nearly one-third also the result of a start-up going public. (See Exhibit 1.)
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?